NASDAQ · Biotechnology

NRSN (NRSN) Stock

$0.42 -1.55% NASDAQ: NRSN Healthcare

Valuation

MetricValue
Price$0.42
Market Cap$14.85M
P/E Ratio-0.92
P/B Ratio-6.70
P/S Ratio0.00
EPS (TTM)$-0.44
52-Week High$1.98
52-Week Low$0.25
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE543.76%
ROA-458.07%
ROCE744.96%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity-0.11
Current Ratio0.33

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-6.0M$-14.0M$-12.0M$-10.0M$-11.0M
Net Profit$-4.0M$-12.0M$-10.0M$-10.0M$-11.0M
EPS$-0.23$-1.07$-0.83$-0.55$-0.44
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$11.0M$8.0M$3.0M$5.0M$1.0M
Total Liabilities$2.0M$2.0M$5.0M$2.0M$3.0M
Cash$11.0M$4.0M$3.0M$3.0M$0
Borrowings$0$0$0$0$0

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-2.0M$-8.0M$-8.0M$-10.0M$-8.0M
Investing Cash Flow$0$-4.0M$3.0M$0$0
Financing Cash Flow$1.0M$0$0$0$0
Net Cash Flow$10.0M$-8.0M$-1.0M$1.0M$-3.0M
Free Cash Flow$-2.0M$-8.0M$-8.0M$-10.0M$-8.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.69
EV / EBITDA-1.31
FCF Yield-25.43%
Quick Ratio0.31
Interest Coverage-652.06
Return 1Y-63.69%
Return 3Y-47.14%
Return 5Y—

About NRSN

NRSN is led by CEO Alon Ben-Noon, employs 17 people, headquartered in IL, publicly traded since 2021.

NRSN stock trades at $0.42 with a market capitalization of $14.85M. The stock is valued at a price-to-earnings (P/E) ratio of -0.92, price-to-book of -6.70, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.25 and $1.98, and currently trades 78.8% below its 52-week high.

On profitability, NRSN generates a return on equity (ROE) of 543.76% — well above the market average, a sign of a high-quality business, return on capital employed of 744.96%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1159.93 +0.28% JNJ Drug Manufacturers - General $271.19 +2.01% ABBV Drug Manufacturers - General $259.99 +1.39% MRK Drug Manufacturers - General $149.94 +1.48% UNH Medical - Healthcare Plans $396.30 +1.77% NVS Drug Manufacturers - General $161.25 +6.04% AZN Drug Manufacturers - General $162.47 +0.21% AMGN Drug Manufacturers - General $438.12 +1.92% TMO Medical - Diagnostics & Research $600.50 -2.69% NVO Biotechnology $45.12 -0.46% ABT Medical - Devices $108.97 -1.26% GILD Drug Manufacturers - General $149.92 +2.45%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides